HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients

The inability of patients with CVID to mount specific antibody responses to pathogens has raised concerns on the risk and severity of SARS-CoV-2 infection, but there might be a role for protective T cells in these patients. SARS-CoV-2 reactive T cells have been reported for SARS-CoV-2 unexposed heal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Steiner, Sophie, Sotzny, Franziska, Bauer, Sandra, Na, Il-Kang, Schmueck-Henneresse, Michael, Corman, Victor M., Schwarz, Tatjana, Drosten, Christian, Wendering, Désirée J., Behrends, Uta, Volk, Hans-Dieter, Scheibenbogen, Carmen, Hanitsch, Leif G.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7785785/
https://ncbi.nlm.nih.gov/pubmed/33424856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.607918
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars